Skip to content
10-Q

Quarterly Report

Horizon Therapeutics Public Ltd Co

0000950170-23-039388

← back to feed
Filed
Aug 8, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2023 · Aug 2, 2023 228.99M sh
Shares Diluted Q2 2023 · Jun 30, 2023 233.94M sh
Shares Diluted Q2 2023 · Jun 30, 2023 233.94M sh
Shares Diluted Q2 2023 · Jun 30, 2022 236.17M sh
Shares Diluted Q2 2023 · Jun 30, 2022 236.08M sh
Capex Q2 2023 · Jun 30, 2023 $42.59M
Capex Q2 2023 · Jun 30, 2022 $24.35M
Operating Cash Flow Q2 2023 · Jun 30, 2023 $247.79M
Operating Cash Flow Q2 2023 · Jun 30, 2022 $464.99M
Long Term Debt Q2 2023 · Jun 30, 2023 $2.54B
Long Term Debt Q2 2023 · Dec 31, 2022 $2.55B
Short Term Debt Q2 2023 · Jun 30, 2023 $16M
Short Term Debt Q2 2023 · Dec 31, 2022 $16M
Cash And Equivalents Q2 2023 · Jun 30, 2023 $2.46B
Cash And Equivalents Q2 2023 · Dec 31, 2022 $2.35B
Stockholders Equity Q2 2023 · Jun 30, 2023 $5.31B
Stockholders Equity Q2 2023 · Mar 31, 2023 $5.1B
Stockholders Equity Q2 2023 · Dec 31, 2022 $5.07B
Stockholders Equity Q2 2023 · Jun 30, 2022 $4.95B
Stockholders Equity Q2 2023 · Mar 31, 2022 $4.82B
Stockholders Equity Q2 2023 · Dec 31, 2021 $4.67B
Current Liabilities Q2 2023 · Jun 30, 2023 $917.68M
Current Liabilities Q2 2023 · Dec 31, 2022 $949.14M
Current Assets Q2 2023 · Jun 30, 2023 $3.92B
Current Assets Q2 2023 · Dec 31, 2022 $3.65B
Total Assets Q2 2023 · Jun 30, 2023 $9.3B
Total Assets Q2 2023 · Dec 31, 2022 $9.11B
Eps Diluted Q2 2023 · Jun 30, 2023 $0.54
Eps Diluted Q2 2023 · Jun 30, 2023 $0.78
Eps Diluted Q2 2023 · Jun 30, 2022 $0.26
Eps Diluted Q2 2023 · Jun 30, 2022 $1.12
Eps Basic Q2 2023 · Jun 30, 2023 $0.56
Eps Basic Q2 2023 · Jun 30, 2023 $0.80
Eps Basic Q2 2023 · Jun 30, 2022 $0.27
Eps Basic Q2 2023 · Jun 30, 2022 $1.16
Sga Expense Q2 2023 · Jun 30, 2023 $434.13M
Sga Expense Q2 2023 · Jun 30, 2023 $887.48M
Sga Expense Q2 2023 · Jun 30, 2022 $398.22M
Sga Expense Q2 2023 · Jun 30, 2022 $770.96M
Rd Expense Q2 2023 · Jun 30, 2023 $150.04M
Rd Expense Q2 2023 · Jun 30, 2023 $284.18M
Rd Expense Q2 2023 · Jun 30, 2022 $103.25M
Rd Expense Q2 2023 · Jun 30, 2022 $206.38M
Net Income Q2 2023 · Jun 30, 2023 $127.07M
Net Income Q2 2023 · Jun 30, 2023 $181.76M
Net Income Q2 2023 · Mar 31, 2023 $54.68M
Net Income Q2 2023 · Jun 30, 2022 $60.97M
Net Income Q2 2023 · Jun 30, 2022 $265.24M
Net Income Q2 2023 · Mar 31, 2022 $204.26M
Operating Income Q2 2023 · Jun 30, 2023 $142.84M
Operating Income Q2 2023 · Jun 30, 2023 $178.84M
Operating Income Q2 2023 · Jun 30, 2022 $88.56M
Operating Income Q2 2023 · Jun 30, 2022 $282.87M
Gross Profit Q2 2023 · Jun 30, 2023 $725M
Gross Profit Q2 2023 · Jun 30, 2023 $1.35B
Gross Profit Q2 2023 · Jun 30, 2022 $646.2M
Gross Profit Q2 2023 · Jun 30, 2022 $1.32B
Cost Of Revenue Q2 2023 · Jun 30, 2023 $219.96M
Cost Of Revenue Q2 2023 · Jun 30, 2023 $428.52M
Cost Of Revenue Q2 2023 · Jun 30, 2022 $230.22M
Cost Of Revenue Q2 2023 · Jun 30, 2022 $445.28M
Revenue Q2 2023 · Jun 30, 2023 $944.96M
Revenue Q2 2023 · Jun 30, 2023 $1.78B
Revenue Q2 2023 · Jun 30, 2022 $876.41M
Revenue Q2 2023 · Jun 30, 2022 $1.76B